COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,304 Articles (22,772 medRxiv, 8,532 bioRxiv)

Most recent first Previous |  Page 2496: Articles 24951-24960  | Next

A minimal model for household effects in epidemics
Huber, G., Kamb, M., Kawagoe, K., Li, L., Veytsman, B., Yllanes, D., Zigmond, D.
10.1101/2020.07.09.20150227 — Posted: 2020-07-11
Eurofins Covid-19 Sentinel TM Wastewater Test Provide Early Warning of a potential COVID-19 outbreak
Jorgensen, A. U., Gamst, J., Hansen, L. V., Knudsen, I. I. H., Jensen, S. K. S.
10.1101/2020.07.10.20150573 — Posted: 2020-07-11
A flexible COVID-19 model to assess mitigation, reopening, virus mutation and other changes
Bienstock, S.
10.1101/2020.07.09.20150029 — Posted: 2020-07-11
What can the ideal gas say about global pandemics? Reinterpreting the basic reproduction number
Dickson, B. M.
10.1101/2020.07.09.20150128 — Posted: 2020-07-11
An exploratory Integrated Moving Average Time Series Model of the initial outbreak of COVID-19 in six (6) significantly impacted Countries
Pascarella, J., Pascarella, E.
10.1101/2020.07.09.20150136 — Posted: 2020-07-11
Estimating the time-varying reproduction number of COVID-19 with a state-space method
Koyama, S., Horie, T., Shinomoto, S.
10.1101/2020.07.09.20150219 — Posted: 2020-07-11
ICU admissions and in-hospital deaths linked to covid-19 in the Paris region are correlated with previously observed ambient temperature
Mejdoubi, M., Kyndt, X., Djennaoui, M.
10.1101/2020.07.10.20150508 — Posted: 2020-07-11
Magnitude and time-course of excess mortality during COVID-19 outbreak: population-based empirical evidence from highly impacted provinces in northern Italy
Conti, S., Ferrara, P., Mazzaglia, G., D'Orso, M. I., Ciampichini, R., Fornari, C., Madotto, F., Magoni, M., Sampietro, G., Silenzi, A., Sileo, C. V., Zucchi, A., Cesana, G., Manzoli, L., Mantovani, L. G.
10.1101/2020.07.10.20150565 — Posted: 2020-07-11
Clinical utility of targeted SARS-CoV-2 serology testing to aid the diagnosis and management of suspected missed, late or post-COVID-19 infection syndromes: results from a pilot service
Sweeney, N., Merrick, B., Pickering, S., Pedro Galao, R., Botgros, A., Wilson, H. D., Signell, A. W., Betancor, G., Tan, M. K. I., Ramble, J., Kouphou, N., Acors, S., Graham, C., Seow, J., MacMahon, E., Neil, S. J. D., Malim, M. H., Doores, K., Douthwaite, S., Batra, R., Nebbia, G., Edgeworth, J. D.
10.1101/2020.07.10.20150540 — Posted: 2020-07-11
Neutralizing Antibody Responses in COVID-19 Convalescent Sera
Lee, W. T., Girardin, R. C., Dupuis, A. P., Kulas, K. E., Payne, A. F., Wong, S. J., Arinsburg, S., Nguyen, F. T., Mendu, D. R., Firpo-Betancourt, A., Jhang, J., Wajnberg, A., Krammer, F., Cordon-Cardo, C., Amler, S., Montecalvo, M. A., Hutton, B., Taylor, J., McDonough, K. A.
10.1101/2020.07.10.20150557 — Posted: 2020-07-11 Discussion: Onsite | Offsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).